San Diego VC Fund's 'Capital Efficient' Biotech Startup Gets Acquired in $1.3B Deal by German Pharma Giant

Avalon BioVentures operates a $135M fund and inks a billion-dollar M&A deal in 2024.

Learn from San Diego's top entrepreneurs and companies. Every week, I write a newsletter breaking down the business and money in San Diego. Join 1,800+ of tech professionals, entrepreneurs, and investors by subscribing below.